Dr Lal Pathlabs Ltd

Dr. Lal PathLabs is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations.(Source : 201903 Annual Report Page No: 86)

  • Market Cap: 13,670 Cr.
  • Current Price: 1,640
  • 52 weeks High / Low 1846.00 / 1025.50
  • Book Value: 123.92
  • Stock P/E: 60.51
  • Dividend Yield: 0.73 %
  • ROCE: 33.24 %
  • ROE: 21.98 %
  • Sales Growth (3Yrs): 15.00 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 10.00
Edit ratios
Pros:
Company is virtually debt free.
Company has a good return on equity (ROE) track record: 3 Years ROE 24.23%
Company has been maintaining a healthy dividend payout of 21.06%
Cons:
Stock is trading at 13.24 times its book value

Peer comparison Sector: Healthcare // Industry: Healthcare

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
249 278 263 267 292 318 292 301 335 366 328 302
184 200 206 203 217 231 227 235 240 257 246 244
Operating Profit 66 78 57 64 75 87 66 66 95 109 82 57
OPM % 26% 28% 22% 24% 26% 27% 22% 22% 28% 30% 25% 19%
Other Income 8 8 7 9 9 11 12 14 14 15 14 12
Interest 0 0 0 0 0 0 0 0 4 4 4 4
Depreciation 7 8 8 11 9 9 10 10 16 18 19 20
Profit before tax 66 78 56 62 75 88 68 69 89 102 73 45
Tax % 33% 35% 35% 35% 34% 35% 32% 32% 34% 21% 25% 28%
Net Profit 44 51 36 40 49 57 46 47 59 80 54 32
EPS in Rs 5.40 6.19 4.39 4.88 6.00 6.92 5.56 5.72 7.14 9.77 6.56 3.94
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
237 342 452 558 660 791 912 1,057 1,203 1,330
181 256 354 419 504 582 675 793 910 987
Operating Profit 57 87 98 139 156 210 238 264 294 344
OPM % 24% 25% 22% 25% 24% 26% 26% 25% 24% 26%
Other Income 2 2 3 8 12 20 27 31 46 55
Interest 1 3 0 0 0 0 1 1 1 15
Depreciation 14 20 20 27 28 28 28 33 38 73
Profit before tax 45 66 80 119 140 201 237 261 301 310
Tax % 34% 32% 31% 33% 31% 34% 34% 34% 33%
Net Profit 29 45 55 80 96 132 155 171 199 226
EPS in Rs 738.08 1,143.39 1,527.46 140.00 16.77 15.99 18.61 20.49 23.90 27.41
Dividend Payout % 19% 19% 9% 7% 9% 15% 16% 22% 25%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:16.62%
3 Years:15.00%
TTM:10.55%
Compounded Profit Growth
10 Years:%
5 Years:19.68%
3 Years:14.19%
TTM:13.40%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:21.85%
1 Year:58.93%
Return on Equity
10 Years:%
5 Years:26.17%
3 Years:24.23%
Last Year:21.98%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
5 5 5 80 81 83 83 83 83 83
Reserves 88 111 157 151 260 424 512 734 890 950
Borrowings 20 0 0 1 0 0 0 0 0 0
59 63 108 146 161 119 95 98 117 342
Total Liabilities 169 177 269 352 475 625 690 916 1,091 1,374
112 108 127 140 150 166 152 208 209 414
CWIP 0 6 1 0 1 4 18 10 3 10
Investments 1 5 55 9 38 64 106 145 185 164
56 58 87 203 286 391 414 554 694 786
Total Assets 169 177 269 352 475 625 690 916 1,091 1,374

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
42 68 88 98 122 159 171 197 219
-19 -26 -64 -89 -113 -163 -137 -172 -100
-22 -38 -15 -10 -1 0 -32 13 -55
Net Cash Flow 1 4 9 -2 8 -5 2 37 64

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 60% 58% 61% 49% 47% 43% 37% 33%
Debtor Days 15 15 16 16 17 17 17 14 16
Inventory Turnover 0.00 0.00 0.00 10.73 12.01 12.15 0.00 0.00